Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis
{{output}}
Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD), characterized with hepatocellular steatosis, ballooning, lobular inflammation, fibrotic progression, and insulin resistance. NASH may progress to cirrhosis a... ...
